Epidemiology

  • Most commonly affects individuals from the Mediterranean region to eastern Asia, with the highest prevalence observed in Turkey and Japan

Etiology

  • Possible autoimmune and infectious triggers (e.g., precipitating HSV or parvovirus infection)
  • Strong HLA-B51 association

Pathophysiology

  • Autoimmune systemic vasculitis that can involve arteries and veins of all sizes
  • Characterized by the deposition of immune complexes, proliferation of CD4+ T cells, and increased cytokines

Clinical features

  • Presents in young adults (20s-40s).
  • Classic triad:
    1. Recurrent, painful oral aphthous ulcers (required for Dx).
    2. Recurrent, painful genital ulcers.
    3. Uveitis (anterior or posterior) or retinal vasculitis. Can lead to hypopyon.
  • Skin Lesions:
    • Erythema nodosum-like lesions (often on shins).
    • Papulopustular or acneiform lesions.
  • Arthritis: Non-erosive, migratory, oligoarticular arthritis, most often affecting knees and ankles.
  • Vascular Manifestations:
    • Thrombosis is common (DVT, cerebral venous sinus thrombosis, Budd-Chiari syndrome).
    • Aneurysms (especially pulmonary artery).
  • Neurologic Manifestations (“Neuro-Behçet’s”):
    • Aseptic meningitis or meningoencephalitis.
    • Brainstem syndromes, cranial nerve palsies.

Mnemonic

PATHERGY: Positive pathergy test, Aphthous oral ulcers, Thrombosis (arterial and venous), Hemoptysis (pulmonary artery aneurysm), Eye lesions (uveitis, retinal vasculitis), Recurrent Genital ulcers, Young at presentation (3rd decade)


Diagnostics

  • Diagnosis is clinical, based on established criteria (International Study Group).
    • Requires recurrent oral ulceration PLUS at least two of the following: recurrent genital ulceration, eye lesions, skin lesions, or a positive pathergy test.
  • Labs are non-specific but show inflammation (↑ ESR, ↑ CRP).
  • No specific autoantibodies are associated with the disease.

Treatment